DNA

Nicholas Navin, PhD, associate professor at the MD Anderson Cancer Center, elaborates on the promise of single-cell sequencing as an innovative, noninvasive tool for research and clinical use.
| 5+ min read

Diagnostic tool that can open a window into a transplant recipient’s immediate future through the analysis of cfDNA
| 3 min read
















